MedTrace Logo

Surgery With Extended (D3) Mesenterectomy for Small Bowel Tumors

NCT05670574 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2023-01-04

No results posted yet for this study

Summary

The study is designed to investigate the safety and efficacy of central D3 lymphadenectomy in cases of small bowel tumors. Such dissection is under debate; consensus guidelines are vague when it comes to surgical techniques and practice is highly variable.

Conditions

  • Small Bowel Cancer
  • Small Bowel Carcinoid Tumor
  • Quality of Life
  • Lymph Node Metastases
  • Tumor Metastasis

Interventions

PROCEDURE

Surgery with extended (D3) mesenterectomy for small bowel tumors

Sponsors & Collaborators

  • Helse Sor-Ost

    collaborator OTHER_GOV

  • University of Geneva, Switzerland

    collaborator OTHER

  • Oslo University Hospital

    collaborator OTHER

  • CarciNor

    collaborator UNKNOWN

  • Sykehuset i Vestfold HF

    lead OTHER

Principal Investigators

  • Dejan Ignjatovic, MD PhD · University Hospital, Akershus

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-11-04
Primary Completion
2025-12-31
Completion
2025-12-31

Countries

  • Norway

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05670574 on ClinicalTrials.gov